Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Natura: Artigo
Lingua:Russo
Pubblicazione: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Serie:Vestnik Transplantologii i Iskusstvennyh Organov
Soggetti:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Accesso online:https://journal.transpl.ru/vtio/article/view/1194
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi